BTCYBIOTRICITY INC.

Nasdaq biotricity.com


$ 1.28 $ -0.07 (-4.95 %)    

Thursday, 02-May-2024 14:48:14 EDT
QQQ $ 433.12 $ 0.80 (0.19 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 510.53 $ 0.00 (0 %)
TLT $ 88.87 $ 0.38 (0.43 %)
GLD $ 213.12 $ -0.66 (-0.31 %)
$ 1.3022
$ 1.34
$ 0.00 x 0
$ 0.00 x 0
$ 1.28 - $ 1.34
$ 0.70 - $ 4.37
43,777
na
11.69M
$ 1.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-20-2024 12-31-2023 10-Q
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 06-29-2023 03-31-2023 10-K
5 02-14-2023 12-31-2022 10-Q
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 07-14-2022 03-31-2022 10-K
9 02-14-2022 12-31-2021 10-Q
10 11-04-2021 09-30-2021 10-Q
11 08-17-2021 06-30-2021 10-Q
12 06-22-2021 03-31-2021 10-K
13 02-16-2021 12-31-2020 10-Q
14 11-13-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 07-15-2020 03-31-2020 10-K
17 02-14-2020 12-31-2019 10-Q
18 11-14-2019 09-30-2019 10-Q
19 08-15-2019 06-30-2019 10-Q
20 07-16-2019 03-31-2019 10-K
21 02-19-2019 12-31-2018 10-Q
22 11-14-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 07-13-2018 03-31-2018 10-K
25 02-14-2018 12-31-2017 10-Q
26 11-14-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 03-30-2017 12-31-2016 10-K
29 11-18-2016 09-30-2016 10-Q
30 08-15-2016 06-30-2016 10-Q
31 05-16-2016 03-31-2016 10-Q
32 12-21-2015 11-30-2015 10-Q
33 11-30-2015 08-31-2015 10-K
34 07-14-2015 05-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 biotricity-announces-high-demand-for-its-lbiotres-pro-a-3-channel-patch-like-ecg-biotres-pro-is-expected-to-raise-the-average-subscription-price-by-over-32-translating-to-revenue-increase-of-up-to-10-from-sales-to-existing-customers-throughout-2025

Biotres Pro Is Also Capturing The Attention Of New Customers. The Initial Production Run Of Biotres Pro Has Sold Out, With Cust...

 why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

 biotricity-unveils-that-improved-margins-resulted-from-latest-advancements-to-its-proprietary-cardiac-ai-cloud-platform-and-announces-plans-for-continued-expansion-of-its-cardiac-ai-cloud

Biotricity's AI automation engine has already proven to increase operational efficiency and support growth, evidenced by th...

 biotricity-q3-2024-adj-eps-012-beats-044-estimate-sales-297m-miss-300m-estimate

Biotricity (NASDAQ:BTCY) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.44) by...

 why-fluor-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

 earnings-scheduled-for-february-20-2024

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue...

 biotricitys-earnings-outlook
Biotricity's Earnings Outlook
02/19/2024 20:01:46

 biotricity-expands-cardiac-ai-cloud-platform-development

Company's growing data ecosystem supports the development of large data models for its future predictive technologies and C...

 hc-wainwright--co-downgrades-biotricity-to-neutral

HC Wainwright & Co. analyst Kevin Dede downgrades Biotricity (NASDAQ:BTCY) from Buy to Neutral.

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 earnings-outlook-for-biotricity
Earnings Outlook For Biotricity
11/13/2023 18:02:00

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION